Liver cancer vaccine with immunotherapy shows promise in new trial
Combining immunotherapy with a personalized anti-tumor vaccine increased tumor shrinkage compared to immunotherapy alone.
Stay updated with breaking news from Hepatobiliary Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Combining immunotherapy with a personalized anti-tumor vaccine increased tumor shrinkage compared to immunotherapy alone.
Researchers from Washington University School of Medicine suggest accelerated biological aging may be driving early-onset cancer rates in young people.
Researchers say metabolic syndrome, which includes conditions such as high cholesterol, obesity, and high blood pressure, increases a person's risk of all types of cancer
In a new study, researchers explain how early-stage cancer cells hide from the immune system. They hope their findings will help improve cancer diagnostics and treatment.
Researchers discovered that people with pancreatic cancer with certain KRAS mutations have better survival rates than those with other mutations. The findings add to existing research on targeting KRAS mutations to develop a cancer vaccine.